Polyphenols Market Size Worth $2.08 Billion By 2025

The global polyphenols market size is expected to reach USD 2.08 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.2% during the forecast period. Growing awareness about effectiveness of polyphenols in treating diabetes, cardiovascular diseases, high cholesterol, and cancer, along with rising number of applications in the food and beverage and pharmaceutical sectors, is anticipated to drive product demand over the forecast period.

Polyphenols extracted from grape seed have antioxidant properties, which play a significant role in beauty products and nutritional skin supplements. These antioxidants bind to the skin collagen and stimulate flexibility, elasticity, and cell health, thus resulting in youthful skin. Rising awareness of herbal products instead of synthetic drugs, coupled with increasing demand for anti-aging products, is expected to boost demand for polyphenols.

Technological advancements enable manufacturers to enhance the benefits of polyphenols in curing various diseases. Moreover, development of cost-effective technology to extract polyphenols from plants, herbs, fruits, and vegetables for human and animal consumption is expected boost market growth over the coming years.

Grape seed polyphenols dominated the global polyphenols market in 2018. Grape seed extract has essential therapeutic properties, including managing poor circulation, nerve damage, cholesterol, macular degeneration, anticancer, and atherosclerosis. According to the United States Food & Drug Administration (FDA), grape seed is more effective than chemotherapy for the treatment of cancer. Grape seed extracts are anticipated to experience high demand on account of surging consumption in the food and beverage, cosmetics, and healthcare industries.

In terms of volume, Asia Pacific emerged as the largest regional market, followed by North America. China, India, South Korea, and Japan are anticipated to witness major product demand in the coming years on account of increasing health awareness among the growing diet-conscious population, seeking functional benefits in every kind of food they consume. Surging population and awareness about polyphenol benefits on human health are expected to drive the market in Asia Pacific.

North America is anticipated to emerge as the second-largest regional market owing to increasing disposable income of consumers, resulting in growing consumption of healthy food and beverages in countries such as U.S. and Canada. Changing demographics and lifestyles, rising health concerns, favorable research studies, and technological developments are anticipated to drive the market over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/polyphenols-market-analysis

Further key findings from the study suggest:

In terms of revenue, the grape seed product segment is expected to expand at a CAGR of 7.3% over the forecast period
In terms of volume, the functional beverages application segment dominated the market with a share of 36.4% in 2018
In U.S., development of preventive healthcare and government focus on improving the national health standard are some of the significant factors contributing to industry growth
Some of the key industry participants present in the market are Cargill, Inc.; Chr. Hansen; Ajinomoto; Archer Daniels Midland (ADM); HERZA Schokolade GmbH & Co. KG; Indena S.p.A.; Martin Bauer Group; and Frutarom Ltd.

Human Milk Oligosaccharides Market Size Worth $101.5 Million By 2027

The global human milk oligosaccharides market size is anticipated to reach USD 101.5 million by 2027, according to a new report by Grand View Research, Inc. It is expected to exhibit a CAGR of 23.0% over the forecast period. Increasing awareness regarding the functions and health benefits associated with Human Milk Oligosaccharides (HMO) is expected to fuel its demand over the forecast period.

Changing consumer lifestyles and their increasing concerns regarding health and wellness are some of the other prominent factors driving the demand for HMOs around the world. Human milk oligosaccharides in functional food and beverage products and food supplements can help the treatment of certain disorders and high-risk health conditions, which in turn is anticipated to boost the product demand. However, high costs associated with the product may challenge the market growth over the forecast period.

Human milk oligosaccharides are a major source of sialic acid, which is an essential part of the plasma membrane of nerve cells. Over 150 structurally diverse HMOs are available in nature. Moreover, scientists have been trying to develop various structures of HMOs synthetically, for use in the food industry-most particularly infant formulas and medical nutrition. These synthetically produced HMOs are safe for consumption by infants (who cannot be breastfed), as well as children and adults.

Human milk oligosaccharides find application in infant formula, functional food and beverages, and food supplements, among others. Increasing health awareness along with the rising consumption of infant formula is likely to boost the growth of the HMO market over the forecast period. The consumption of HMOs has contributed significantly to bring about a considerable reduction in the global infant mortality rate over the years. As per the United Nations International Children’s Education Fund (UNICEF), the under-five mortality rate was one per 11 children in 1990 which dropped to one per 26 children in 2018.

Infant formula is the largest and fastest-growing application segment for human milk oligosaccharides. High infant mortality rate and rising concerns regarding health and safety are the factors likely to boost the market growth over the forecast period. HMOs play a key role in the proper development of infants. They fight life-threatening infections and are also responsible for the proper development of the brain and gut.

Human milk oligosaccharides are also increasingly utilized in pharmaceutical applications. Furthermore, the prebiotic effects of HMOs make them suitable to be used in functional foods and beverages, and food supplements. Functional foods and beverages is the second-largest application segment of HMOs. The demand for HMOs in designing infant formulas is increasing because of the beneficial properties, such as prevention from infection, memory enhancement, brain development, prebiotic effects, and improvement of gut health.

Asia Pacific is expected to be a lucrative market for human milk oligosaccharides and is expected to account for a significant share of the global HMO market revenue by 2027. The increasing demand for infant formulas and functional food and beverages as well as the rapidly growing pharmaceutical industry is expected to positively influence the market growth over the forecast period.

Recent years have witnessed various developments in the infant formula space with prominent end-use companies launching new and innovative products. For instance, in April 2019, Nestlé S.A., a Switzerland-based food and beverage company, introduced three new products in the U.K., namely, SMA Advanced Follow-on Formula, SMA Advanced Growing up Milk, and SMA Advanced Infant Formula. These products contained artificial HMOs and were intended for infants who were not breastfed. Such developments within the infant formula sector are likely to drive the demand for human milk oligosaccharides in near future.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/human-milk-oligosaccharides-market

Further key findings from the report suggest:

In terms of application, the infant formula segment is expected to expand at a CAGR of 23.4% over the forecast period. Challenges associated with breast-feeding, such as personal comfort, time, diet, and frequency of feedings have led to the increase in the consumption of infant formula, contributing to the segment growth
Incorporation of HMOs in functional food and beverages promotes the growth of good bacteria and eliminates harmful bacteria including salmonella, listeria, and campylobacter
Growing consumption of functional foods and beverages for improving gut health and overall immunity is expected to have significant impacts on the demand for human milk oligosaccharides over the forecast period
Distribution agreements, capacity expansions, and investments for the development of low-cost technologies are some of the major strategies adopted by the prominent market players to establish strong competitive positions in the HMO market

Bromelain Market Size Worth $59.2 Million By 2025

The global bromelain market is expected to reach USD 59.2 million by 2025, growing at a CAGR of 8.7%, according to a new report by Grand View Research, Inc. Rising expenditure in R&D to use bromelain to cure diseases such as cancer & acquired immune deficiency syndrome (HIV AIDS) is expected to have a positive impact on the market during forecast period.

This digestive enzyme is extracted from pineapple fruit & stem and is used in numerous industries including healthcare, meat & seafood, dietary supplements, cosmetics, bakery and beverage. Globally, meat & seafood industry is found to be the largest end user industry for this market where its main application is to improve tenderness of meat & seafood.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/bromelain-market

Further key findings from the report suggest:

Meat & seafood was the largest application segment, accounting for 56.8% of the global market volume in 2016. Rising importance of functional ingredients in meat & seafood industry for enhancing the properties of finished food products as a result of technological innovation is expected to promote the use of bromelain.
Healthcare industry accounted for 25.5% of global market share in 2016 and is expected to grow at a CAGR of 9.2 %, by volume in between 2017-2022. As per World bank, global healthcare industry is expected to witness a global GDP expenditure of around 10.5% by 2020. Around USD 8.7 trillion is expected to be spent in this industry every year till 2020. Emerging technologies in developed nations and emergence of demand for the product in the developing nations are the two factors which are expected to drive the market during the forecast period.
North America accounted for 26.8% of the overall volume market share in 2016 and is expected to maintain its position over the next eight years. Growth in meat & seafood sector coupled with surge in R&D in healthcare sector are the two major factors helping North America to maintain its position.
Key industry participants include Enzybel International SA, Great Food (Biochem) Co., Ltd, Hong Mao Biochemicals Co., Ltd., Biozym Gesellschaft für Enzymtechnologie mbH, Enzyme Technology (PTY) Ltd, Guangxi Nanning Javely Biological Products Co., Ltd, and Nanning Doing-Higher Bio-Tech Co., Ltd.
Advantages such as easy procurement of raw material, low production cost and non-toxicity are major reasons leading to increase its demand over other proteolytic enzymes like actinidin from kiwifruit and ficin from figs.

Chicory Market Size Worth $294.2 Million by 2025

The global chicory market size is anticipated to reach USD 294.2 million by 2025, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 4.2% during the forecast period. Increasing awareness regarding the medicinal value of chicory is the main factor driving the growth.

The chicory root product segment accounted for more than 65% market share in 2018. Roots are a rich source of inulin and nutrients essential for brain health. Ground and roasted roots are used as an alternative to coffee. Chicory root powder is used in baked goods and other food products as an alternative to sugar and fat, as well as, as a texturizer. As a result, the market is anticipated to witness significant rise in demand over the forecast period.

Food and beverage was the largest application segment accounting for more than 45% market share in 2018. It is expected to maintain its dominance throughout the forecast period. Increasing demand for chicory coffee in Thailand, Japan, Netherlands, Germany, France, and U.S. is driving the growth. In addition, increasing use of the product as an alternative to sugar and fat in various food and beverages is expected to create growth opportunities in the forthcoming years.

Europe is anticipated to continue leading the global chicory market over the forecast period. Rising consumption owing to various health benefits of the product is driving the regional growth. Belgium is the largest producer of chicory in the world. Germany, France, and Netherlands are expected to witness significant growth owing to rising consumption of chicory coffee. North America is expected to witness the fastest CAGR of 5.2% from 2019 to 2025 owing to increasing cultivation and consumption of chicory as an alternative to coffee. Growing popularity of chicory as a natural appetizer is anticipated to further fuel the regional growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/chicory-market

Further key findings from the report suggest

Chicory root is expected to witness a CAGR of 4.5% over the forecast period, owing to increasing awareness regarding the health benefit of the roots
U.S. is one of the largest consumers of the product and accounted for more than 85% share of the North America chicory market in 2018
India, Thailand, China, Japan, and Australia are the key markets for chicory in the Asia Pacific region
Belgium, France, and Netherlands held more than 60% share of the Europe market for chicory in 2018

Nutraceutical Market Size Worth $722.49 Billion By 2027

The global nutraceutical market size is projected to reach USD 722.49 billion by 2027, expanding at a CAGR of 8.3% over the forecast period, according to a new report by Grand View Research, Inc. Rising awareness regarding calorie reduction and weight loss in countries, including U.S., China, and India, is expected to promote the application of nutraceuticals, which, in turn, will have a substantial impact on the industry growth.

Nutraceuticals are products that provide health advantages and additional nutrition to the human body. It comprises of fortified nutrients, such as taurine, CoQ10, omega-3, calcium, zinc, and antioxidants, that enhance the complete health of consumers. These nutrients further help in averting medical conditions, such as hypertension, diabetes, heart diseases, and allergies. Demand for nutraceuticals is increasing at the global level as it improve the digestive and immune systems and enhance the cognitive behavior of consumers.

Growing trend among consumers to alter dietary habits is likely to boost the demand for nutraceuticals. The consumer belief that improper diet results in increase in costs on pharmaceuticals is anticipated to boost the demand for nutraceuticals. This would also help the government as it would result in lesser expenditure on healthcare and low social security costs.

Rise in disposable income, increasing consumer awareness concerning health issues, and rapid urbanization are likely to boost the nutraceutical market growth over the forecast years. Positive outlook towards medical nutrition owing to increasing weight management programs, along with cardiovascular diseases, is anticipated to propel the demand for nutraceuticals.

The rise and evolution of wellness focused diets, such as keto and paleo, are driving food producers to cater their products in this direction. Functional food products, such as probiotics and omega-3, are highly used in yogurt and fish oils in order to reduce the risk of cardiovascular diseases and develop the quality of intestinal microflora, which is further projected to fuel the market growth of the nutraceutical products over the coming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/nutraceuticals-market

Further key findings from the study suggest:

Based on functional food product, prebiotics and probiotics are projected to expand at a CAGR of 10.1% over the forecast period owing to increasing usage of probiotics as a primary ingredient among majority of food manufacturing companies to provide better nourishment and reduce health problems caused by harmful bacteria
Vitamins and minerals together accounted for over 40.71% share in 2019 owing to increasing consumer interest in the relationship between diet and health, which, in turn, has increased demand for these products
In terms of dietary supplement product, vitamins emerged as the largest segment in 2019, and is expected to expand at a CAGR of 5.8% in the coming years
In terms of product, functional food accounted for the largest share in 2019 and generated revenue of USD 187.51 billion. Rising healthcare costs, coupled with growing geriatric population across the world, are anticipated to drive the functional food segment over the forecast period
Asia Pacific is expected to witness the fastest growth over the forecast period. Expansion of the retail chain in countries, such as India, Japan, and China, has increased the consumption of dietary supplements and functional foods in this region
The nutraceuticals industry represents a highly competitive landscape. Key players dominate the nutraceutical market space and have been focusing on various strategic initiatives, including mergers & acquisitions, product innovation, and portfolio expansion
Key market participants include Cargill, Incorporated, Archer Daniels Midland Company, DuPont, Nestle S.A, Danone, General Mills, Innophos, WR Grace, and Amway Corporation.